Company Filing History:
12 out of 131,744 
1 out of 485 
Years Active: 2015-2020
Title: Bo Gyou Kim: Innovator in Cancer Treatment
Introduction
Bo Gyou Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development. With a total of 12 patents to his name, Kim has established himself as a leading figure in the medical and pharmaceutical industries.
Latest Patents
Among his latest patents is the development of a biomarker known as PNCK, which is designed to predict the efficacy of a dual-targeting agent that targets both c-Met and EGFR. This invention includes a method for selecting subjects for the application of this dual-targeting agent and monitoring its effects by measuring the levels of PNCK and/or its coding gene. Another notable patent involves a polypeptide, an anti-VEGF antibody, and an anti-c-Met/anti-VEGF bispecific antibody, which are crucial for treating cancer. This patent also encompasses a pharmaceutical composition that includes the antibody and outlines a method for cancer treatment using the antibody.
Career Highlights
Throughout his career, Bo Gyou Kim has worked with esteemed organizations such as Samsung Electronics Co., Ltd. and Georgetown University. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research endeavors.
Collaborations
Some of his notable coworkers include Kyung Ah Kim and Ji Min Lee. Their collaborative efforts have contributed to the advancement of innovative solutions in cancer treatment.
Conclusion
Bo Gyou Kim's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. His patents and collaborations highlight his commitment to improving patient outcomes through advanced research and development.